[go: up one dir, main page]

SK284476B6 - Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu - Google Patents

Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu Download PDF

Info

Publication number
SK284476B6
SK284476B6 SK1431-2000A SK14312000A SK284476B6 SK 284476 B6 SK284476 B6 SK 284476B6 SK 14312000 A SK14312000 A SK 14312000A SK 284476 B6 SK284476 B6 SK 284476B6
Authority
SK
Slovakia
Prior art keywords
acid
effervescent
formulations according
effervescent formulations
cetirizine
Prior art date
Application number
SK1431-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK14312000A3 (sk
Inventor
Wolfram Tritthart
Mario Andr Piskernig
Original Assignee
Viatris Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh & Co. Kg filed Critical Viatris Gmbh & Co. Kg
Publication of SK14312000A3 publication Critical patent/SK14312000A3/sk
Publication of SK284476B6 publication Critical patent/SK284476B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
SK1431-2000A 1998-03-31 1999-03-20 Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu SK284476B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (fr) 1998-03-31 1999-03-20 Formulations solides et a decomposition rapide contenant de la cetirizine

Publications (2)

Publication Number Publication Date
SK14312000A3 SK14312000A3 (sk) 2001-07-10
SK284476B6 true SK284476B6 (sk) 2005-04-01

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1431-2000A SK284476B6 (sk) 1998-03-31 1999-03-20 Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu

Country Status (30)

Country Link
US (1) US6245353B1 (fr)
EP (1) EP1067904B1 (fr)
JP (1) JP2002509873A (fr)
KR (1) KR100653568B1 (fr)
CN (1) CN1136838C (fr)
AR (1) AR018828A1 (fr)
AT (1) ATE209899T1 (fr)
AU (1) AU750140B2 (fr)
BG (1) BG64741B1 (fr)
BR (1) BR9909233A (fr)
CA (1) CA2326809C (fr)
CY (1) CY1107331T1 (fr)
CZ (1) CZ300704B6 (fr)
DE (2) DE19814256A1 (fr)
DK (1) DK1067904T3 (fr)
ES (1) ES2168013T3 (fr)
HU (1) HU227477B1 (fr)
IL (1) IL138606A (fr)
NO (1) NO329071B1 (fr)
NZ (1) NZ506988A (fr)
PL (1) PL191266B1 (fr)
PT (1) PT1067904E (fr)
RU (1) RU2216318C2 (fr)
SI (1) SI1067904T1 (fr)
SK (1) SK284476B6 (fr)
TR (1) TR200002809T2 (fr)
TW (1) TWI233808B (fr)
UA (1) UA57615C2 (fr)
WO (1) WO1999049843A1 (fr)
ZA (1) ZA200005134B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1224423C (zh) * 2000-07-17 2005-10-26 山之内制药株式会社 改善口服吸收的医药组合物
KR101005648B1 (ko) * 2002-01-15 2011-01-05 유씨비 파쉼 소시에떼아노님 제형
MXPA04009617A (es) * 2002-04-04 2005-01-11 Pfizer Prod Inc Comprimido masticable con sabor agradable.
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
LT2522365T (lt) 2004-11-24 2017-02-10 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
JP2009517346A (ja) 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
AU2009288006B2 (en) * 2008-09-05 2014-07-17 Mcneil-Ppc, Inc. Method for making cetirizine tablets
PE20120647A1 (es) * 2009-03-13 2012-05-31 Nucitec Sa De Cv Composiciones y metodos para el tratamiento y prevencion de la enfermedad cardiovascular
EP2571484A2 (fr) * 2010-05-18 2013-03-27 Mahmut Bilgic Formulations effervescentes
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
CN104363897A (zh) 2012-06-12 2015-02-18 宝洁公司 泡腾剂型
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3061501A1 (fr) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition pour le traitement de l'acné
EP3117825A1 (fr) 2015-07-16 2017-01-18 Rottapharm S.p.A. Formulation orale comprenant de la berbérine et un extrait de morus alba
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (fr) * 2017-11-15 2019-05-23 Berkeley Nox Limited Nouveaux compléments alimentaires
PT3799864T (pt) 2019-10-02 2023-05-25 Intas Pharmaceuticals Ltd Composições farmacêuticas sólidas efervescentes essencialmente isentas de sódio
EP4099977A1 (fr) * 2020-02-03 2022-12-14 Johnson & Johnson Consumer Inc. Comprimé à mâcher monocouche comprenant de la cétirizine
CN120437087A (zh) 2024-02-01 2025-08-08 科赴品牌有限责任公司 一种口腔溶解膜制剂、其用途及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
SK279279B6 (sk) * 1991-05-13 1998-09-09 The Boots Company Plc S(-)-nátrium-2-(4-izobutylfenyl)propionát-dihydrát
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
NZ256346A (en) * 1992-10-09 1997-04-24 Procter & Gamble Medicaments containing 3-l-menthoxypropane-1,2-diol for treating cold symptoms
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
EP0624364B1 (fr) * 1993-04-15 1996-07-24 Gerhard Dr. Gergely Système effervescent contenant un principe actif sensible aux alcalis et/ou aux métaux, et procédé pour sa production
CA2161217A1 (fr) * 1993-04-30 1994-11-10 Carmelita Macklin Russell Compositions pharmaceutiques garnies d'un revetement
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
CY1107331T1 (el) 2012-12-19
HU227477B1 (en) 2011-07-28
CN1136838C (zh) 2004-02-04
EP1067904B1 (fr) 2001-12-05
IL138606A0 (en) 2001-10-31
KR20010034718A (ko) 2001-04-25
US6245353B1 (en) 2001-06-12
CA2326809C (fr) 2008-11-18
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
DE19814256A1 (de) 1999-10-07
HUP0102676A2 (hu) 2001-11-28
HK1036217A1 (en) 2001-12-28
NO20004722D0 (no) 2000-09-21
EP1067904A1 (fr) 2001-01-17
IL138606A (en) 2005-07-25
SI1067904T1 (en) 2002-04-30
WO1999049843A1 (fr) 1999-10-07
RU2216318C2 (ru) 2003-11-20
NZ506988A (en) 2002-05-31
DE59900501D1 (de) 2002-01-17
ES2168013T3 (es) 2002-05-16
PL343199A1 (en) 2001-07-30
ATE209899T1 (de) 2001-12-15
BR9909233A (pt) 2000-11-28
ZA200005134B (en) 2000-12-21
CZ300704B6 (cs) 2009-07-22
AR018828A1 (es) 2001-12-12
DK1067904T3 (da) 2002-04-02
SK14312000A3 (sk) 2001-07-10
BG64741B1 (bg) 2006-02-28
BG104843A (en) 2001-07-31
JP2002509873A (ja) 2002-04-02
PL191266B1 (pl) 2006-04-28
CZ20003481A3 (en) 2001-05-16
HUP0102676A3 (en) 2002-12-28
UA57615C2 (uk) 2003-06-16
AU3925399A (en) 1999-10-18
TWI233808B (en) 2005-06-11
CN1295464A (zh) 2001-05-16
NO329071B1 (no) 2010-08-16
CA2326809A1 (fr) 1999-10-07
TR200002809T2 (tr) 2000-12-21
AU750140B2 (en) 2002-07-11
KR100653568B1 (ko) 2006-12-05

Similar Documents

Publication Publication Date Title
SK284476B6 (sk) Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu
KR101020809B1 (ko) 펙소페나딘을 함유하는 구강 분산성 정제
ES2462536T3 (es) Comprimido orodispersable multicapa
EP1370247B1 (fr) Compositions pharmaceutiques au gout dissimule
US8048449B2 (en) Mouth dissolving pharmaceutical composition and process for preparing the same
US6242002B1 (en) Effervescent formulations
KR100854033B1 (ko) 구강에서 신속히 붕해되는 갈레닉 제제 및 그의 제조방법
US6482823B1 (en) Taste masked pharmaceutical liquid formulations
US20050112196A1 (en) Rapidly disintegrating formulation
US8663682B2 (en) Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles
US20110046115A1 (en) Mirtazapine Solid Dosage Forms
KR20100086140A (ko) 몬테루카스트를 활성성분으로 함유하는 구강 내 속붕해정 조성물 및 그 제조방법
KR100604034B1 (ko) 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물
MXPA00009349A (en) Solid, quick dissolving cetirizine formulations
HK1036217B (en) Solid, quick dissolving cetirizine formulations

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20170320